Skip to main content
. 2021 Dec 12;28(6):5304–5317. doi: 10.3390/curroncol28060443

Figure 3.

Figure 3

Relationship between PFS and tumor necrosis after neoadjuvant chemotherapy. Data show progression-free survival for patients with ≥90% tumor necrosis (blue curve) and <90% necrosis (orange curve) after neoadjuvant chemotherapy in the adult cohort (a) and the pediatric cohort (b).